Peginterferon alfa-2b and ribavirin treatment response among Hispanic veterans with chronic hepatitis C genotype 1

被引：1
|
作者：
Toro, D [1 ]
De Jesus, JJ [1 ]
Rodriguez-Perez, F [1 ]
Gonzalez, D [1 ]
Rivera, I [1 ]
机构：
[1] San Juan Vet Affairs Med Ctr, San Juan, PR USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00301
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
301
引用
收藏
页码：S122 / S123
页数：2
相关论文
共 50 条
  • [41] Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
    Zeuzem, S
    Buti, M
    Ferenci, P
    Sperl, J
    Horsmans, Y
    Cianciara, J
    Ibranyi, E
    Weiland, O
    Noviello, S
    Brass, C
    Albrecht, J
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 97 - 103
  • [42] Evaluating rapid virological response reduces ribavirin and peginterferon alfa-2b treatment costs for chronic hepatitis C in the United Kingdom
    Wong, JB
    Rosenberg, WM
    Manns, MP
    Davis, GL
    McHutchison, JG
    Albrecht, JK
    Group, IHIT
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 181 - 182
  • [43] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Tatsuo Kanda
    Fumio Imazeki
    Ryosaku Azemoto
    Yutaka Yonemitsu
    Shigeru Mikami
    Kazuhiko Kita
    Motohide Takashi
    Masahiko Sunaga
    Shuang Wu
    Shingo Nakamoto
    Akinobu Tawada
    Makoto Arai
    Keizo Kato
    Yu Yoshida
    Yoshihiro Koma
    Keiichi Fujiwara
    Kenichi Fukai
    Noriaki Suzuki
    Osamu Yokosuka
    [J]. Digestive Diseases and Sciences, 2011, 56 : 3335 - 3342
  • [44] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [45] Sustained viral response (SVR) with Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who were non responders (NR) to Peginterferon alfa-2b and ribavirin
    Gitlin, N
    Muther, KD
    [J]. HEPATOLOGY, 2004, 40 (04) : 343A - 343A
  • [46] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [47] Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaiVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1
    Manns, Michael P.
    Poordad, Fred
    Bacon, Bruce R.
    Bruno, Savino
    Esteban, Rafael
    Silva, Marcelo O.
    Buti, Maria
    Burroughs, Margaret
    Sniukiene, Vilma
    Boparai, Navdeep
    Brass, Cliflord A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S942 - S942
  • [48] Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites (vol 350, pg 2265, 2004)
    Muir, AJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12): : 1268 - 1268
  • [49] Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
    Buti, M
    Sanchez-Avila, F
    Lurie, Y
    Stalgis, C
    Valdés, A
    Martell, M
    Esteban, R
    [J]. HEPATOLOGY, 2002, 35 (04) : 930 - 936
  • [50] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 79 - 79
12345